About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Wockhardt Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Abbott India
26827.45
332.3
1.25
717.26
37.4
408
-13.98
1.77
1978.48
Neuland Laboratories
13095.8
288.95
2.26
138.99
94.22
2065
24.95
0.09
1182.3
NGL Fine-Chem
2405.5
112.45
4.9
48.17
49.94
1494
140.55
0.07
452.6
Procter&Gamble Healt
4987.9
76.8
1.56
176.81
28.21
488
-3.89
2.51
320.52
Torrent Pharma
4371.05
33.55
0.77
64.97
67.27
9174
47.69
0.73
224.32
Acutaas Chemicals
2191.2
32.5
1.51
35.66
61.45
12133
104.23
0.03
160.19
JB Chem & Pharma
2075.1
22.2
1.08
45.3
45.81
4120
29.95
0.75
206.14
Sun Pharma Inds.
1752.7
14.6
0.84
16.77
104.51
107135
10.57
0.91
101.45
FDC
370.85
13.95
3.91
13.95
26.59
7372
-3.41
1.35
140.48
Kerala Ayurveda
216.15
10.5
5.11
-15.52
0
31288
-36.15
0
15.71
Lupin
2311.6
10.25
0.45
120.21
19.23
17859
18.42
0.52
529.92
Dr. Reddy's Lab
1294.65
7.45
0.58
55.59
23.29
90879
15.61
0.62
344.27
Cipla
1351.85
4.2
0.31
57.14
23.66
28979
-3.95
1.18
396.82
Eris Lifesciences
1363.35
4.15
0.31
20.44
66.71
3843
15.56
0.54
183.9
Anlon Healthcare
111.65
3.15
2.9
3.86
28.92
53720
0
20.18
Alivus Life Sciences
915.9
2.8
0.31
44.3
20.68
9818
-2.08
0.55
229.11
Parmax Pharma
32.97
2.77
9.17
-13.55
0
105
-22.77
0
-7.21
iStreet Network
41.49
1.97
4.98
0.74
56.13
39286
828.19
0.24
-0.71
Bliss GVS Pharma
213.8
1.9
0.9
7.17
29.8
51363
75.53
0.23
99.87
Senores Pharmaceutic
765.85
1.8
0.24
2.99
255.77
5972
44.39
0
153.74
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.